Mohammad Sajad Emami Aleagha
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Mohammad Sajad Emami Aleagha has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
Reza Yarani
Translational Type 1 Diabetes Biology, Department of Clinical Research, Steno Diabetes Center Copenhagen, Copenhagen, Denmark
6 shared publications- Abdolamir Allameh
Department of Clinical Biochemistry, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
4 shared publications Bahaadin Siroos
Department of Neurology, Iranian Centre of Neurological Research, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
3 shared publicationsMohammad Balood
Department of Clinical Biochemistry, AJA University of Medical Sciences, Tehran, Iran
3 shared publicationsMohammad Hossein Harirchian
Department of Neurology, Iranian Centre of Neurological Research, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
3 shared publications- Mohammad Hossein Harirchian
Iranian Center of Neurological Research , Neuroscience Institute , Tehran University of Medical Sciences , Tehran , Iran , tums.ac.ir
3 shared publications
Latest Publications
- 26 April 2022
- Published by Springer Nature in Amino Acids
- Vol. 54 (6) , 841-858
The potential roles of amino acids and their major derivatives in the management of multiple sclerosis
Recently, we reviewed the important role of carbohydrates and lipids metabolism in different clinical aspects of multiple sclerosis (MS) disease. In the current paper, we aimed to review the contribution of amino acids and their major derivatives to different clinical outcomes of the disease, including etiology, pathogenesis, diagnosis, prognosis, and treatment. In this line, Thr (threonine), Phe (phenylalanine), Glu (glutamate), Trp (tryptophan), and Sero (serotonin) are the main examples of biomolecules that have been suggested for MS therapy. It has been concluded that different amino acids and their derivatives might be considered prominent tools for the clinical management of MS disease.
- 26 April 2022
- Published by Springer Nature in Amino Acids
- Vol. 54 (6) , 841-858
The potential roles of amino acids and their major derivatives in the management of multiple sclerosis
Recently, we reviewed the important role of carbohydrates and lipids metabolism in different clinical aspects of multiple sclerosis (MS) disease. In the current paper, we aimed to review the contribution of amino acids and their major derivatives to different clinical outcomes of the disease, including etiology, pathogenesis, diagnosis, prognosis, and treatment. In this line, Thr (threonine), Phe (phenylalanine), Glu (glutamate), Trp (tryptophan), and Sero (serotonin) are the main examples of biomolecules that have been suggested for MS therapy. It has been concluded that different amino acids and their derivatives might be considered prominent tools for the clinical management of MS disease.
- 1 November 2021
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 712, 109030
Carbohydrate and lipid metabolism in multiple sclerosis: Clinical implications for etiology, pathogenesis, diagnosis, prognosis, and therapy
- 1 November 2021
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 712, 109030
Carbohydrate and lipid metabolism in multiple sclerosis: Clinical implications for etiology, pathogenesis, diagnosis, prognosis, and therapy
- 5 June 2021
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 42 (7) , 2121-2129
HIF-1α in the Crosstalk Between Reactive Oxygen Species and Autophagy Process: A Review in Multiple Sclerosis
Cellular stress can lead to the production of reactive oxygen species (ROS) while autophagy, as a catabolic pathway, protects the cells against stress. Autophagy in its turn plays a pivotal role in the pathophysiology of multiple sclerosis (MS). In the current review, we first summarized the contribution of ROS and autophagy to MS pathogenesis. Then probable crosstalk between these two pathways through HIF-1α for the first time has been proposed with the hope of employing a better understanding of MS pathophysiology and probable therapeutic approaches.
- 5 June 2021
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 42 (7) , 2121-2129
HIF-1α in the Crosstalk Between Reactive Oxygen Species and Autophagy Process: A Review in Multiple Sclerosis
Cellular stress can lead to the production of reactive oxygen species (ROS) while autophagy, as a catabolic pathway, protects the cells against stress. Autophagy in its turn plays a pivotal role in the pathophysiology of multiple sclerosis (MS). In the current review, we first summarized the contribution of ROS and autophagy to MS pathogenesis. Then probable crosstalk between these two pathways through HIF-1α for the first time has been proposed with the hope of employing a better understanding of MS pathophysiology and probable therapeutic approaches.
- Open Access
- 3 March 2021
- Published by Wiley in Journal of Medical Virology
- Vol. 93 (7) , 4081-4082
Letter to Editor in response to the article “Vitamin D insufficiency as a potential culprit in critical COVID‐19 patients”
We carefully read the meta‐analysis article on the association between serum vitamin D status and outcome of COVID‐19 by Munshi et al.
- 3 March 2021
- Published by Wiley in Journal of Medical Virology
- Vol. 93 (7) , 4081-4082
Open AccessLetter to Editor in response to the article “Vitamin D insufficiency as a potential culprit in critical COVID‐19 patients”
We carefully read the meta‐analysis article on the association between serum vitamin D status and outcome of COVID‐19 by Munshi et al.
- 1 March 2019
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 328, 89-93
Calcitriol, but not FGF23, increases in CSF and serum of MS patients
- 1 March 2019
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 328, 89-93
Calcitriol, but not FGF23, increases in CSF and serum of MS patients
- 1 January 2019
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 59, 51-54
C/EBP homologous protein investigation in the serum and cerebro-spinal fluid of relapsing-remitting multiple sclerosis patients
- 1 January 2019
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 59, 51-54
C/EBP homologous protein investigation in the serum and cerebro-spinal fluid of relapsing-remitting multiple sclerosis patients
- Open Access
- 1 May 2018
- Vol. 9 (3) , 206-210
Cross-talks between the kidneys and the central nervous system in multiple sclerosis
Multiple sclerosis (MS) is an inflammatory demyelinating disease, which is considered as a common autoimmune disorder in young adults. A growing number of evidences indicated that the impairment in non-neural tissues plays a significant role in pathology of MS disease. There are bidirectional relationship, metabolic activities and functional similarity between central nervous system (CNS) and kidneys which suggest that kidney tissue may exert remarkable effects on some aspects of MS disorder and CNS impairment in these patients compels the kidney to respond to central inflammation. Recently, it has been well documented that hormonal secretion possesses the important role on CNS abnormalities. In this regard, due to the functional similarity and significant hormonal and non-hormonal relationship between CNS and kidneys, we hypothesized that kidneys exert significant effect on initiation, progression or amelioration of MS disease which might be regarded as potential therapeutic approach in the treatment of MS patients in the future.
- 1 May 2018
- Vol. 9 (3) , 206-210
Open AccessCross-talks between the kidneys and the central nervous system in multiple sclerosis
Multiple sclerosis (MS) is an inflammatory demyelinating disease, which is considered as a common autoimmune disorder in young adults. A growing number of evidences indicated that the impairment in non-neural tissues plays a significant role in pathology of MS disease. There are bidirectional relationship, metabolic activities and functional similarity between central nervous system (CNS) and kidneys which suggest that kidney tissue may exert remarkable effects on some aspects of MS disorder and CNS impairment in these patients compels the kidney to respond to central inflammation. Recently, it has been well documented that hormonal secretion possesses the important role on CNS abnormalities. In this regard, due to the functional similarity and significant hormonal and non-hormonal relationship between CNS and kidneys, we hypothesized that kidneys exert significant effect on initiation, progression or amelioration of MS disease which might be regarded as potential therapeutic approach in the treatment of MS patients in the future.
- 14 March 2018
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 64 (4) , 543-550
Differential Expression of Klotho in the Brain and Spinal Cord is Associated with Total Antioxidant Capacity in Mice with Experimental Autoimmune Encephalomyelitis
Recently, we reported a positive correlation between Klotho, as an anti-aging protein, and the total antioxidant capacity (TAC) in cerebrospinal fluid (CSF) of multiple sclerosis (MS) patients. However, there is no information about the Klotho and TAC changes within the central nervous system (CNS). Thus, the current study aimed to employ an experimental autoimmune encephalomyelitis (EAE) model in C57BL/6 mice using MOG35–55 peptide to examine the relationship between Klotho and TAC within the CNS. To this end, the brain and spinal cord were obtained at the onset and peak stages of EAE as well as non-EAE mice (sham/control groups). The Klotho expression was assessed in the brain and spinal cord of different experimental groups at mRNA (qPCR) and protein (ELISA) levels. Also, TAC level was determined in the tissues of different experimental groups. The results showed that Klotho expression in the brain at the onset and peak stages of EAE were significantly lower than that in non-EAE mice. Conversely, Klotho expression in the spinal cord at the onset of EAE was significantly higher than that of non-EAE mice, while Klotho was comparable at the peak stage of EAE and non-EAE mice. The pattern of TAC alteration in the brain and spinal cord of EAE mice was similar to that of Klotho expression. In conclusion, for the first time, this study demonstrated a significant positive correlation between Klotho and TAC changes during the pathogenesis of EAE. It is suggested that Klotho may have neuroprotective activity through the regulation of redox system.
- 14 March 2018
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 64 (4) , 543-550
Differential Expression of Klotho in the Brain and Spinal Cord is Associated with Total Antioxidant Capacity in Mice with Experimental Autoimmune Encephalomyelitis
Recently, we reported a positive correlation between Klotho, as an anti-aging protein, and the total antioxidant capacity (TAC) in cerebrospinal fluid (CSF) of multiple sclerosis (MS) patients. However, there is no information about the Klotho and TAC changes within the central nervous system (CNS). Thus, the current study aimed to employ an experimental autoimmune encephalomyelitis (EAE) model in C57BL/6 mice using MOG35–55 peptide to examine the relationship between Klotho and TAC within the CNS. To this end, the brain and spinal cord were obtained at the onset and peak stages of EAE as well as non-EAE mice (sham/control groups). The Klotho expression was assessed in the brain and spinal cord of different experimental groups at mRNA (qPCR) and protein (ELISA) levels. Also, TAC level was determined in the tissues of different experimental groups. The results showed that Klotho expression in the brain at the onset and peak stages of EAE were significantly lower than that in non-EAE mice. Conversely, Klotho expression in the spinal cord at the onset of EAE was significantly higher than that of non-EAE mice, while Klotho was comparable at the peak stage of EAE and non-EAE mice. The pattern of TAC alteration in the brain and spinal cord of EAE mice was similar to that of Klotho expression. In conclusion, for the first time, this study demonstrated a significant positive correlation between Klotho and TAC changes during the pathogenesis of EAE. It is suggested that Klotho may have neuroprotective activity through the regulation of redox system.
- 1 October 2017
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 381, 305-307
Klotho gene expression decreases in peripheral blood mononuclear cells (PBMCs) of patients with relapsing-remitting multiple sclerosis
- 1 October 2017
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 381, 305-307
Klotho gene expression decreases in peripheral blood mononuclear cells (PBMCs) of patients with relapsing-remitting multiple sclerosis
- 1 May 2017
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 14, 29-31
Soluble CD40 ligand derived from serum is not correlated with early MS
- 1 May 2017
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 14, 29-31
Soluble CD40 ligand derived from serum is not correlated with early MS